| ACC | acetyl-CoA carboxylase |
| AKI | acute kidney injury |
| AMPK | AMP-activated protein kinase |
| ATP | adenosine triphosphate |
| CKD | chronic kidney injury |
| eGFR | estimated glomerular filtration rate |
| ESRD | end stage renal disease |
| FADH2 | flavin adenine dinucleotide |
| FDA | Food and Drug Administration |
| FGF23 | fibroblast growth factor 23 |
| GFR | glomerular filtration rate |
| GLP-1 | glucagon-like peptide 1 |
| IR | ischemia-reperfusion |
| i.v. | intravenous |
| KDOQI | kidney disease outcomes quality initiative |
| LKB1 | liver kinase B1 |
| MALA | metformin-associated lactic acidosis |
| MATE1 | multidrug and toxin extrusion 1 |
| MATE2 | multidrug and toxin extrusion 2 |
| mTOR | mammalian target of rapamycin |
| NADH | nicotinamide adenine dinucleotide |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NFκB, | nuclear factor kappa B |
| NKF | national kidney foundation |
| OCT1 | organic cation transporter 1 |
| OCT2 | organic cation transporter 2 |
| p.o. | per os |
| ROS | reactive oxygen species |
| T2DM | type 2 diabetes mellitus |
| TGF-β2 | transforming growth factor β2 |
| ULK1 | uncoordinated-51 like kinase 1 |